10-methyl spiro(4.5)dec-6-en-6-carboxylic acid has been researched along with Hyperglycemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Braciale, TJ; Cheon, IS; Colca, JR; Jackson, PEH; Jones, RG; Kaplan, MH; Krawczyk, CM; Li, C; Mann, BJ; Narasimhan, H; Pandey, A; Qian, W; Somerville, L; Sturek, JM; Sun, J; Vassallo, RA; Wei, X; Wu, Y; Zhang, R; Zhu, B | 1 |
1 other study(ies) available for 10-methyl spiro(4.5)dec-6-en-6-carboxylic acid and Hyperglycemia
Article | Year |
---|---|
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19.
Topics: Animals; Blood Glucose; COVID-19; Diabetes Mellitus; Humans; Hyperglycemia; Mice; Monocarboxylic Acid Transporters; SARS-CoV-2 | 2023 |